| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.16 | 0.0006 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.084 | 0.06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.087 | 0.07 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.089 | 0.08 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.082 | 0.09 |